COLLEGIUM PHARMACEUTICAL, INC·4

Feb 7, 4:11 PM ET

Malamut Richard 4

4 · COLLEGIUM PHARMACEUTICAL, INC · Filed Feb 7, 2020

Insider Transaction Report

Form 4
Period: 2020-02-05
Malamut Richard
EVP and Chief Medical Officer
Transactions
  • Award

    Common Stock

    2020-02-05+20,25062,750 total
  • Award

    Stock Option (Right to Purchase)

    2020-02-05+22,50022,500 total
    Exercise: $21.34Exp: 2030-02-05Common Stock (22,500 underlying)
Footnotes (2)
  • [F1]Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2021, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock.
  • [F2]Twenty-five percent (25%) of the option vests and becomes exercisable on February 10, 2021, and the balance vests in equal quarterly installments (rounded up to the nearest whole share of common stock) over the following three-year period, subject to the reporting person's continued service with the issuer.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT